NeuroMetrix (NURO) News Today → [Shocking] Elon Musk’s Plan To End Banks (From Crypto 101 Media) (Ad) Free NURO Stock Alerts $4.57 +0.24 (+5.54%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNeuroMetrix appoints new board director, ends ATM facilityinvesting.com - April 20 at 6:57 PMNeuroMetrix Rises 18% After Announcement Of Shareholder Value Enhancement Stepsmarkets.businessinsider.com - April 19 at 2:51 PMNeuroMetrix, Inc.: NeuroMetrix Announces Steps Taken to Enhance Shareholder Valuefinanznachrichten.de - April 19 at 9:50 AMNeuroMetrix Announces Steps Taken to Enhance Shareholder Valueglobenewswire.com - April 19 at 8:00 AMNeuroMetrix (NASDAQ:NURO) Coverage Initiated by Analysts at StockNews.comamericanbankingnews.com - April 18 at 2:30 AMNeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathyglobenewswire.com - March 14 at 9:00 AMNeuroMetrix, Inc.: NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell Fibromyalgiafinanznachrichten.de - March 13 at 10:19 PMNeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgiaglobenewswire.com - March 13 at 9:00 AMRS Fund Management LLC: RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.finanznachrichten.de - March 8 at 2:12 PMRS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.finance.yahoo.com - March 8 at 2:12 PMGoogle releases new open LLMs, Rivian lays off staff and Signal rolls out usernamesau.lifestyle.yahoo.com - February 25 at 9:19 AMNeuroMetrix Full Year 2023 Earnings: US$6.08 loss per share (vs US$4.96 loss in FY 2022)finance.yahoo.com - February 24 at 12:41 PMNeuroMetrix, Inc. (NASDAQ:NURO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 23 at 4:00 PMNeuroMetrix, Inc.: NeuroMetrix Reports Q4 and Full Year 2023 Business Highlightsfinanznachrichten.de - February 22 at 8:37 AMNeuroMetrix Reports Q4 and Full Year 2023 Business Highlightsfinance.yahoo.com - February 22 at 8:37 AMNeuroMetrix Reports Q4 and Full Year 2023 Business Highlightsglobenewswire.com - February 22 at 7:00 AMNeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Callfinance.yahoo.com - February 15 at 11:31 AMNeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Callglobenewswire.com - February 15 at 9:00 AMNeuroMetrix, Inc.: NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Valuefinanznachrichten.de - February 13 at 4:30 PMNeuroMetrix Plans Strategic Options To Promote Growth, Maximize Shareholder Value; Stock Dropsmarkets.businessinsider.com - February 13 at 4:30 PMNeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Valuefinance.yahoo.com - February 13 at 10:32 AMNeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024finance.yahoo.com - January 8 at 1:17 PMNeuroMetrix, Inc.: NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell in Post-Acute COVID-19 Syndrome (Long COVID)finanznachrichten.de - December 12 at 1:12 PMNeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)finance.yahoo.com - December 12 at 1:12 PMNeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)finance.yahoo.com - December 5 at 10:09 AMOPEN, AMPE and NURO are among pre market gainersmsn.com - November 30 at 1:46 PMmarketbeat.com - November 22 at 6:02 AMNeuroMetrix, Inc.: NeuroMetrix Announces One-for-Eight Reverse Stock Splitfinanznachrichten.de - November 20 at 3:35 PMNeuroMetrix Announces One-for-Eight Reverse Stock Splitfinance.yahoo.com - November 20 at 10:30 AMNeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023finance.yahoo.com - October 30 at 9:24 AMNeuroMetrix, Inc. (NASDAQ:NURO) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - October 28 at 2:23 PMNeuroMetrix reports Q3 resultsmsn.com - October 26 at 11:51 AMNeuroMetrix Reports Q3 2023 Business Highlightsfinance.yahoo.com - October 26 at 11:51 AMNeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Callfinance.yahoo.com - October 23 at 1:27 PMNeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgiafinance.yahoo.com - October 2 at 4:17 PMNeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023finance.yahoo.com - September 28 at 12:38 PMNeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023finance.yahoo.com - August 30 at 5:19 PMIs NeuroMetrix (NURO) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trapfinance.yahoo.com - August 28 at 12:19 PMNeuroMetrix, Inc.: NeuroMetrix Reports Q2 2023 Business Highlightsfinanznachrichten.de - July 27 at 9:42 AMNeuroMetrix Reports Q2 2023 Business Highlightsfinance.yahoo.com - July 27 at 9:42 AMNeuroMetrix, Inc. Announces Date for Second Quarter 2023 Business and Financial Highlights Conference Callfinance.yahoo.com - July 20 at 3:01 PMNeuroMetrix Announces Sales Force Expansion for Quell Fibromyalgiafinance.yahoo.com - July 11 at 10:53 AMRecent Publications Demonstrate Utility of DPNCheck® for Identifying High-Risk Diabetes Patientsfinance.yahoo.com - June 28 at 9:39 AMDiabetic Peripheral Neuropathy Screening That Includes DPNCheck® Predicts Mortality In A Prospective Clinical Studyfinance.yahoo.com - June 7 at 9:54 AMQuell® Demonstrates Encouraging Clinical Trial Results in Chemotherapy Induced Peripheral Neuropathy (CIPN)finance.yahoo.com - May 31 at 1:07 PMAutonomous delivery vehicle startup Nuro is cutting staff and production to focus on R&Dbizjournals.com - May 16 at 8:11 PMNeuroMetrix Reports Q1 2023 Financial Resultsfinance.yahoo.com - May 3 at 7:36 AMNeuroMetrix, Inc. Announces Date for First Quarter 2023 Financial Results Conference Callfinance.yahoo.com - April 28 at 11:14 AMNeuroMetrix to Exhibit Quell® Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meetingfinance.yahoo.com - March 21 at 1:14 PMWhy NeuroMetrix (NURO) Stock Is Soaring Todaythestreet.com - March 14 at 1:50 AM Get NeuroMetrix News Delivered to You Automatically Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter. Email Address [Shocking] Elon Musk’s Plan To End Banks (Ad)Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy. NURO Media Mentions By Week NURO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NURO News Sentiment▼0.140.47▲Average Medical News Sentiment NURO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NURO Articles This Week▼50▲NURO Articles Average Week Get NeuroMetrix News Delivered to You Automatically Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GBS News Today Vivos Therapeutics News Today Plus Therapeutics News Today Avinger News Today Titan Medical News Today Venus Concept News Today Minerva Surgical News Today Acutus Medical News Today Sharps Technology News Today Assure News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NURO) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroMetrix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
